{"disease":{"id":"exocrine-pancreatic-insufficiency","name":"exocrine pancreatic insufficiency"},"drugs":{"marketed":[{"drug_id":"pancrelipase","indication_name":"Exocrine Pancreatic Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PANCRELIPASE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":36,"revenue":null,"mechanism":"Pancreatic enzyme products catalyze the breakdown of fats, proteins, and starches in the duodenum and proximal small intestine, mimicking natural pancreatic enzymes."},{"drug_id":"pancrelipase","indication_name":"Exocrine Pancreatic Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PANCRELIPASE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":36,"revenue":null,"mechanism":"Pancreatic enzyme products catalyze the breakdown of fats, proteins, and starches in the duodenum and proximal small intestine, mimicking natural pancreatic enzymes."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05450627","title":"Registry of Pancreatic Exocrine Insufficiency.","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Hospital Clinico Universitario de Santiago","has_results":false},{"nct_id":"NCT06278272","title":"AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients","phase":"","overall_status":"COMPLETED","enrollment_count":504,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07512934","title":"Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"West Kazakhstan Marat Ospanov Medical University","has_results":false},{"nct_id":"NCT04548778","title":"BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Bühlmann Laboratories AG","has_results":false},{"nct_id":"NCT05112328","title":"The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding","phase":"NA","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03236038","title":"Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT05385211","title":"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Ciusss de L'Est de l'Île de Montréal","has_results":false},{"nct_id":"NCT05480241","title":"Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Unidade Local de Saúde de Coimbra, EPE","has_results":false},{"nct_id":"NCT06756503","title":"Exocrine Pancreatic Insufficiency and Functional Dyspepsia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":65,"lead_sponsor_name":"Maria Marta Piskorz","has_results":false},{"nct_id":"NCT06757348","title":"Fatty Liver and Pancreatic Steatosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":61,"lead_sponsor_name":"Maria Marta Piskorz","has_results":false},{"nct_id":"NCT06691893","title":"Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06477159","title":"Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT05082051","title":"Oral CDX-7108 in Healthy Adults and EPI Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Société des Produits Nestlé (SPN)","has_results":false},{"nct_id":"NCT06052293","title":"Phase 1 Study to Assess Safety and Efficacy of ANG003","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Anagram Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04690738","title":"Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation","phase":"","overall_status":"SUSPENDED","enrollment_count":50,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT03746483","title":"OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Entero Therapeutics","has_results":true},{"nct_id":"NCT05710315","title":"Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure","phase":"NA","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Inova Health Care Services","has_results":false},{"nct_id":"NCT04375878","title":"OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Entero Therapeutics","has_results":true},{"nct_id":"NCT05719311","title":"Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Entero Therapeutics","has_results":true},{"nct_id":"NCT04966897","title":"Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"GlycosBio, Inc.","has_results":false},{"nct_id":"NCT03859869","title":"A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04315311","title":"Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"AbbVie","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}